![]() |
|
|
3 USDA Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND 58202 and 4 University of North Dakota, Grand Forks, ND 58202
* To whom correspondence should be addressed. E-mail: jhunt{at}gfhnrc.ars.usda.gov.
| ABSTRACT |
|---|
|
|
|---|
2.5 g Ca/kg diet is associated with similar threshold responses in bone breaking strength and related biomechanics as well as trabecular structural properties. There was no evidence of a relative P deficiency or of improved or impaired bone strength and structure as Ca intakes increased beyond those needed to maximize bone density.
| Introduction |
|---|
|
|
|---|
Although animal models can be used to directly test the effects of diet on bone strength, most animal studies have tended to focus on determining the Ca requirement to improve either bone mass or density (8). In addition, such studies have tended to use a constant Ca:phosphorus (P) molar ratio, whereas Ca supplementation of human diets commonly does not include P. The objective of the present investigation was to test the influence of increasing dietary Ca concentrations (without increasing dietary P), from nutritionally inadequate to copious levels, on bone mineral density, structure, and breaking strength biomechanics.
| Methods |
|---|
|
|
|---|
4 wk old; initial body weights were (mean ± SD) 59 ± 4 g. The rats were assigned randomly, with blocking for body weight, to 7 dietary treatment groups containing 8 rats each.
The experimental diets were modified from the AIN-93G diet (10) to obtain Ca concentrations of 1, 2, 3, 4, 5, 6, and 7 g/kg diet, with Ca lactate as the Ca source, substituted for equal weights of dietary cornstarch. The resulting analyzed Ca concentrations of the diets were 1.09, 2.12, 3.25, 4.26, 5.22, 6.27, and 7.28 g/kg, respectively (Table 1). All other dietary components (e.g. P) were kept constant. The AIN-93G diet (10) provided 25 µg cholecalciferol and 3 g P/kg, the latter from a combination of potassium phosphate and casein (10). Thus, Ca:P molar ratios were
0.25, 0.50, 0.75, 1.0, 1.3, 1.5, and 1.8 for the present study. Dietary intake was monitored intermittently (daily for 4 d/wk) by weighing consumption without adjustment for spillage.
|
Physical and biomechanical testing. Volumetric bone density of the left tibia was determined by Archimedes's principle. After degassing the bone in deionized water, the bone was weighed while submerged and again after removal from the water (11).
Biomechanical assessment of the breaking of the left femur was conducted by a 3-point bending test using a custom-made apparatus. Interfaced with a computer, this apparatus consists of 2 supports (fulcra) and a movable crosshead driven by a step motor. The increase in force corresponding to each downward movement of the crosshead (0.0169 µm) was measured with an electronic load cell until fracture. The resulting force-displacement data were used together with an electronic digital caliper (0.01 mm resolution; Fred V. Fowler) and microscopic (40x magnification) measurements of bone geometry to determine breaking force, bending moment, stress, and modulus of elasticity with formulas described by Crenshaw et al. (12).
Bone structural analysis. The right proximal tibia was prepared for scanning electron microscopy and structural analysis. The bone was cut longitudinally in a plane that passed perpendicular to a line segment extending from the crest of the tibia to the fibula attachment and through the lateral edge of the cruciate ligament insertion. The cut bone sample was fixed in 10% buffered formalin prior to incubation with 5% H2O2 and then 15% KOH. Soft tissue debris was removed in demineralized, deionized water and the sample was prepared for scanning electron microscopy according to standard procedures (13). Briefly, the sample was dehydrated in a graded series of ethyl alcohol concentrations, critical point dried with CO2, attached to aluminum specimen holders with colloidal silver, sputter-coated with palladium-gold, and examined by scanning electron microscopy (Amray 1000A). Subsequently, the colloidal silver was removed with a razor blade and the sample was stored in mineral oil in preparation for structural analysis by microcomputed topography (micro-CT).5
Bone structural measurements were conducted with a MicroCT 40 (Scanco USA) capable of analyzing the 3-dimensional architecture of the bone. To create a region of interest (ROI), the proximal tibia was placed in a 20.5-mm-diameter tube and imaged every 10 µm in the same sagittal plane as the cut surface at high resolution (55 kVp; 145 µA; each scanned twice and averaged) to obtain an ROI comprised of 418 serial slices. Following acquisition of the spatial data, structural analysis was accomplished with a dedicated computer program (microCT 40 software; version 4.04; Scanco USA) (14). A volume of interest (VOI) that contained only trabecular primary and secondary spongiosa was defined within the ROI (Fig. 1A). The VOI consisted of 100 consecutive image sagittal slices, each 10 µm in width, and was bounded medially as the first slice located from the medial periosteal tibial surface at a distance equal to 25% of width of the proximal tibial growth plate (GP) measured in the sagittal plane at the widest point; laterally as slice 100 of 100 slices; proximally by the interface between the GP and the primary spongiosa; distally by the transverse plane that intersected the secondary spongiosum at a distance measured from the center of the GP equal in length to the width of the GP; and anteriorly and posteriorly by the respective peripheral trabecular-cortical bone interfaces.
|
Chemical analyses of diet and tissues. Following biomechanical assessment, the left femur was demarrowed with cold 0.25 mol/L sucrose, pulverized in liquid nitrogen, lyophilized, and diluted in 6 mol/L HCl (1:5 wt:vol), then analyzed colorimetrically for hydroxyproline using Ehrlich's reagent (17).
Serum alkaline phosphatase was measured colorimetrically (18). Diet and tissue samples were analyzed for Ca concentrations by inductively coupled argon plasma emission spectrophotometry after nitric acid and hydrogen peroxide digestion. Analytical accuracy was monitored by assaying a locally prepared typical diet standard, yielding results that were (mean ± SD) 102 ± 8% of established acceptable values.
Statistics. The effects of dietary treatment were determined by using ANOVA, with Tukey's pairwise contrasts to compare between treatment groups (SAS version 9.1.3) (19). A change point (broken line) model (20) was used to analyze the relationship between dietary Ca concentrations and different bone parameters, assuming an asymptote with a slope of 0 and defining the Ca requirement as the change point. The NLIN procedure in SAS was used to estimate the change point and appropriate 95% CI. Results were considered significant at P <0.05.
| Results |
|---|
|
|
|---|
The serum alkaline phosphatase concentration was significantly greater than in all other groups, which did not differ from one another, in the rats fed the lowest level of dietary Ca, 1 g/kg (Table 2). Femur hydroxyproline concentrations were not affected by dietary Ca (Table 2). Tibia Ca concentrations increased in a stepwise fashion between 1 and 3 g Ca/kg diet, reaching a threshold concentration that remained unchanged between 3 and 7 g/kg (Table 2). Data were similar when expressed on a per tibia basis, although without a significant difference between rats fed 2 and 3 g Ca/kg diet. The tibia P concentration also was significantly lower in rats fed the diet lowest in Ca than in all other groups, but it did not differ among those fed between 3 and 7 g/kg (Table 2). The Ca:P molar ratio of the tibia did not differ among the groups (data not shown). There was no evidence of soft tissue calcification, based on the lack of significant difference among the groups in the Ca concentration of the kidney or gastrocnemious muscle (Table 2).
|
|
|
|
2.5 g/kg diet) were sufficient to reach a threshold response in most of the measured parameters of bone density, biomechanical strength, and structure (Fig. 3). An exception to this was a greater Ca requirement (3.9 g/kg diet) to maximize biomechanical stress. The results using tibia weight or trabecular thickness as dependent variables did not fit this model well and were not used to estimate the Ca requirement.
|
| Discussion |
|---|
|
|
|---|
2.5 g/kg diet, when dietary P and vitamin D requirements were met and kept constant.
The greater Ca requirement estimated using the criterion of biomechanical stress (Fig. 3) in contrast with the other dependent bone-related variables was unexpected. The present finding that the Ca requirement to reach maximum bone stress was greater than that to reach maximum bending moment, is contrary to observations by Miller et al. (21), as discussed by Crenshaw et al. (12). Stress is a measure of the amount of force per unit area (12), which adjusts the bending moment to take into account the area and the geometrical shape of the bone. For these tibia measurements, the cross-section of bone where force is applied is assumed to be elliptical, an assumption that is obviously not strictly met with these biological samples. Given that the other biomechanical measurements, including bending moment, suggest a Ca requirement of
2.5 g/kg diet, the greater Ca requirement derived with the stress measurement should be viewed with caution. A further limitation of the present broken line modeling was the small number of groups consuming less than the requirement. Although the stress parameter maximized at 3.9 g/kg diet by this modeling (Fig. 3), the mean stress measurement was not different in rats fed between 3 and 7 g Ca/kg diet (Table 3).
The present data, showing effects of Ca deficiency that were corrected in rats fed 2–3 g Ca/kg diet without differences among those fed between 3 and 7 g Ca/kg, are generally consistent with more limited published observations relating dietary Ca to the biomechanical properties of bone. Breitman et al. (22) found no difference in the bone biomechanical strength, measured by 3-point flexure testing of the femurs (as in the present study) of 90-d-old ovariectomized rats fed either 2 or 25 g Ca/kg diet. Won et al. (23), also used the 3-point flexure method with femurs of rats and found that the breaking force was significantly reduced in rats fed 0.2 g Ca/kg diet but reached a maximum threshold that did not differ among those fed 3, 6, 10, and 20 g Ca/kg (between 12 and 16 wk of age), with a constant dietary P (5.5 g/kg) nearly twice that of the dietary P used in the present study.
The present findings on a response threshold for the morphological properties of bone are also consistent with more limited published observations. Medeiros et al. (24) found lower femur density (measured by dual X-ray absorptiometry) and reduced strength (by 3-point flexure testing) in rats fed 1 vs. 5.2 g Ca/kg diet for 5 wk. In their reported micro-CT measurements with vertebrae, the Ca-deficient diet resulted in lower relative bone volume (BV/TV), trabecular number and thickness, and greater trabecular separation and SMI, indicating a more rod-like rather than plate-like structure (24), all of which were fully consistent with the present micro-CT observations with the tibia (Table 4). Turner et al. (25) found similar differences when comparing 1.25 to 5.0 g Ca/kg diet, although only in rats treated from 3 to 19 wk old; Ca deficiency did not affect older rats treated from 3 to 51 wk. Zhang et al. (26), studying 12-mo-old rats, found that Ca supplementation [56 mg Ca/(kg body weight·d)] of a diet containing 9 g Ca/kg diet did not influence micro-CT measurements (BV/TV, connectivity density, tabecular number, separation, thickness, or SMI) of the femur greater trochanter region. Together, these observations indicate that bone biomechanics and morphology are substantially influenced by dietary Ca deficiency but otherwise reach a response threshold, and that older rats are less susceptible to deficiency than younger rats.
Bone mass depends on dietary P as well as Ca (8,27,28) and a relative P deficiency has been proposed as a possible explanation for increased fracture risk with a high Ca intake (7). Shapiro and Heaney (27) demonstrated that the femur strength of growing rats was impaired with inadequate dietary P (0.75 g/kg diet) and that increases in dietary Ca (1.25, 2.50, or 3.75 g/kg diet) did not effectively improve femur strength unless the Ca source also provided P. An excess of P (6, 12, or 18 g P/kg diet compared with 3 g P/kg diet) increased the Ca loss from the 45Ca-labeled skeleton of rats 8–14 mo of age (28) and the 2 highest P intakes significantly reduced bone weight, Ca, and P. However, the present results do not support concerns that an increase in dietary Ca without an accompanying increase in dietary P may adversely affect bone biomechanics and fracture risk. With a constant and adequate P concentration of 3 g/kg diet, increases in dietary Ca within the range of 3–7 g Ca/kg diet did not influence femur strength or flexibility.
The present study resulted in somewhat lower estimates of Ca requirements than previous investigations testing the effect of dietary Ca concentration on bone Ca retention. Bernhart et al. (8) reported that 3.4 g Ca/kg diet resulted in maximal mineralization of bone in 24- to 28-d-old rats studied for 3 wk. Similarly, Kaup et al. (29) reported that the tibia Ca concentration maximized in weanling rats fed
3.6 g Ca/kg for 4 wk and Forbes et al. (30) reported maximum femur Ca in young rats fed
4 g Ca/kg diet for 4 wk. The Ca requirements for laboratory rats set by the NRC (31) at 5 g Ca/kg diet were based on 3- to 4-wk studies with rapidly growing rats such as those cited above. [The NRC requirements also considered the concerns about the influence of Ca:P ratios on development of nephrocalcinosis, which can be influenced by other dietary factors such as potassium and magnesium (10)]. The generally lower requirement of
2.5 g Ca/kg diet for maximal bone mineralization in the present study is likely because the longer (13 wk) duration reduced the overall rate of bone growth and development. Whereas maximal bone mineralization required >3 g Ca/kg diet in the 3- to 4-wk studies cited above, there was no evidence of bone impairment by any parameter in rats fed 3 g Ca/kg diet for 13 wk in the present study. This suggests that any possible short-term impairments in bone mineralization in an earlier, more rapid period of growth may be compensated for with additional "catch-up" time consuming 3 g Ca/kg diet.
Of course, the interpretation of this research is limited by the use of laboratory rats. As indicated above, the rats' young age likely increased their Ca requirements and responsiveness to dietary differences compared with older rats. The rats in this and most other studies were also relatively sedentary, without substantial load-bearing exercise that may influence the effect of dietary Ca on bone morphology (32).
In addition, there is uncertainty in comparing the mineral concentration of rat diets to the content of human diets. The use of body surface area is recommended as the basis for conversions of the dose of experimental drugs between species (33). The rats in the present study, with a mean body weight of
150 g, consumed
15 g diet/d (Table 1), so the 1 g Ca/kg diet is equivalent to 0.1 g Ca/kg body weight for the rats, or using a conversion based on body surface area, 0.016 g Ca/kg body weight for humans. Thus, the dietary Ca concentrations in the present study would be equivalent to
1 to 7 g/d for a 60-kg human, a range extending from near to well above the amounts recommended for Ca intake (2). Therefore, the present research suggests a threshold response in bone mass, morphology, and biomechanical properties that is stable across a wide range of dietary Ca intakes that meet or exceed Ca requirements. Additional Ca consumption without additional P neither enhanced nor impaired these bone properties.
Although the lowest dietary Ca concentration in the present study was inadequate for bone development in these weanling rats, it is less likely to be inadequate in fully grown rats (25) or in adult humans. The differences between rats fed the 1 and 2 g Ca/kg diets in the present study, such as the 8% increase in bone density, 16% increase in tibia Ca, 160% increase in bending moment, and 320% increase in bone volume density in rats fed the latter diet substantially exceed the small differences observed in children's total bone mineral content or upper limb mineral density (3), as well as the
1–2% differences observed in adult bone density (4) in human Ca supplementation trials. These responses in human trials, without a clear reduction in the incidence of fractures (4), suggest that the initial Ca status of the subjects in these trials may be close to meeting or exceeding Ca requirements for maximizing bone mass and strength.
The Ca intake required for Ca sufficiency has been difficult to define. Limited Ca balance data have been used to estimate Ca intakes associated with threshold responses in both adolescents (34,35) and adults (2), but there was no suggestion of a threshold response in Ca balance with more extensive balance data in adults (36). In the Women's Health Initiative clinical trial (37), supplementation of 36,282 postmenopausal women with 1000 mg Ca and 400 IU (10 µg) of vitamin D for 1 y increased hip bone density by 1.06% (and the risk of renal calculi), without significantly increasing spine or whole body bone density or significantly reducing the risk of hip, spine, or total fractures [although hip fractures were reduced with Ca plus vitamin D supplementation in a subgroup identified as more adherent (37)]. In that study, baseline Ca intakes were 1150 mg/d and one-third of subjects consumed <800 mg/d, but corrections for baseline Ca intakes did not modify the nonsignificant effect of Ca plus vitamin D supplementation on fracture risk. The results from the present study with young rats cannot help resolve the problem of estimating dietary requirements for human Ca sufficiency but do suggest that once such requirements have been met, additional Ca is unlikely to improve bone mass, structure, or strength.
In conclusion, Ca deficiency clearly impaired bone mass, morphology, and biomechanical properties in growing rats, but these parameters stabilized with Ca intakes of
2.5 g/kg diet and were not further improved or impaired with additional dietary Ca. Dietary P remained constant at recommended levels and there was no indication of a relative P deficiency adversely affecting bone with increasing Ca intake. It is important to define sufficient Ca intakes for humans, as further increases in dietary Ca are unlikely to be beneficial.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Author disclosures: J. R. Hunt, C. D. Hunt, C. A. Zito, J. P. Idso, and L. K. Johnson, no conflicts of interest. ![]()
5 Abbreviations used: BV/TV, bone volume/total volume; GP, growth plate; micro-CT, microcomputed topography; ROI, region of interest; SMI, structural model index; VOI, volume of interest. ![]()
Manuscript received 10 March 2008. Initial review completed 8 May 2008. Revision accepted 20 May 2008.
| LITERATURE CITED |
|---|
|
|
|---|
1. NIH Consensus Development Panel. Optimal calcium intake. JAMA. 1994;272:1942–8.
2. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997.
3. Winzenberg T, Shaw K, Fryer J, Jones G. Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials. BMJ. 2006;333:775.
4. Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Ortiz Z, Peterson J, Adachi J, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev. 2002;23:552–9.
5. Crenshaw TD. Reliability of dietary Ca and P levels and bone mineral content as predictors of bone mechanical properties at various time periods in growing swine. J Nutr. 1986;116:2155–70.
6. Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner-H-W MJM, Cedel SL, Melton LJd. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med. 1990;322:802–9.[Abstract]
7. Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Burckhardt P, Li R, Spiegelman D, Specker B, Orav JE, Wong JB, et al. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr. 2007;86:1780–90.
8. Bernhart FW, Savini S, Tomarelli RM. Calcium and phosphorus requirements for maximal growth and mineralization of the rat. J Nutr. 1969;98:443–8.
9. Institute of Laboratory Animal Research; Commission on Life Sciences, NRC. Guide for the care and use of laboratory animals. Washington, DC: National Academy of Sciences; 1996.
10. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939–51.
11. Kalu DN, Liu CC, Hardin RR, Hollis BW. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology. 1989;124:7–16.
12. Crenshaw RD, Peo JER, Lewis AJ, Moser BD. Bone strength as a trait for assessing mineralization in swine: a critical review of techniques involved. J Anim Sci. 1981;53:827–35.
13. Newman SM Jr, McDonald IC, Triebold B. Antennal sexual dimorphism in Diabrotica virgifera fergifera (Le Conte) (Coleoptera: Chrysomelidae): male specific structures, ultrastructure of a unique sensillum, and sites of esterase activity. Int J Insect Morphol Embryol. 1993;22:535–47.
14. Hanson NA, Bagi CM. Alternative approach to assessment of bone quality using micro-computed tomography. Bone. 2004;35:326–33.[Medline]
15. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res. 1999;14:1167–74.[CrossRef][Medline]
16. Odgaard A, Gundersen HJ. Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. Bone. 1993;14:173–82.[Medline]
17. Podenphant J, Larsen NE, Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta. 1984;142:145–8.[CrossRef][Medline]
18. Tietz NW, Burtis CA, Duncan P, Ervin K, Petitclerc CJ, Rinker AD, Shuey D, Zygowicz ER. A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem. 1983;29:751–61.
19. SAS Institute Inc. SAS OnlineDoc. 9.1.3. Cary (NC): SAS Institute, Inc.; 2004.
20. Bacon DW, Watts DG. Estimating the transition between two intersecting straight lines. Biometrika. 1971;58:525–34.
21. Miller ER, Ullrey DE, Zutaut CL, Baltzer BV, Schmidt DA, Hoefer JA, Luecke RW. Calcium requirement of the baby pig. J Nutr. 1962;77:7–17.
22. Breitman PL, Fonseca D, Ward WE. Combination of soy protein and high dietary calcium on bone biomechanics and bone mineral density in ovariectomized rats. Menopause. 2005;12:428–35.[CrossRef][Medline]
23. Won JH, Fukuda S, Sato R, Naito Y. Bone histomorphometric changes due to differences in calcium intake under metabolic acidosis in rats. J Vet Med Sci. 1996;58:611–6.[Medline]
24. Medeiros DM, Stoecker B, Plattner A, Jennings D, Haub M. Iron deficiency negatively affects vertebrae and femurs of rats independently of energy intake and body weight. J Nutr. 2004;134:3061–7.
25. Turner CH, Hinckley WR, Wilson ME, Zhang W, Dunipace AJ. Combined effects of diets with reduced calcium and phosphate and increased fluoride intake on vertebral bone strength and histology in rats. Calcif Tissue Int. 2001;69:51–7.[Medline]
26. Zhang G, Qin L, Hung WY, Shi YY, Leung PC, Yeung HY, Leung KS. Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Bone. 2006;38:818–25.[Medline]
27. Shapiro R, Heaney RP. Co-dependence of calcium and phosphorus for growth and bone development under conditions of varying deficiency. Bone. 2003;32:532–40.[Medline]
28. Draper HH, Sie TL, Bergan JG. Osteoporosis in aging rats induced by high phosphorus diets. J Nutr. 1972;102:1133–41.
29. Kaup SM, Greger JL, Lee K. Nutritional evaluation with an animal model of cottage cheese fortified with calcium and guar gum. J Food Sci. 1991;56:692–5.
30. Forbes RM, Weingartner KE, Parker HM, Bell RR, Erdman JW Jr. Bioavailability to rats of zinc, magnesium and calcium in casein-, egg- and soy protein-containing diets. J Nutr. 1979;109:1652–60.
31. NRC. Nutrient requirements of laboratory animals. 4th revised ed. Washington, DC: National Academy of Sciences; 1995.
32. Specker B, Binkley T. Randomized trial of physical activity and calcium supplementation on bone mineral content in 3- to 5-year-old children. J Bone Miner Res. 2003;18:885–92.[CrossRef][Medline]
33. U.S. Department of Health and Human Services; FDA, Center for Drug Evaluation and Research. Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Rockville (MD): Food and Drug Administration; 2005. p. 6–7.
34. Jackman LA, Millane SS, Martin BR, Wood OB, McCabe GP, Peacock M, Weaver CM. Calcium retention in relation to calcium intake and postmenarcheal age in adolescent females. Am J Clin Nutr. 1997;66:327–33.
35. Braun M, Martin BR, Kern M, McCabe GP, Peacock M, Jiang Z, Weaver CM. Calcium retention in adolescent boys on a range of controlled calcium intakes. Am J Clin Nutr. 2006;84:414–8.
36. Hunt CD, Johnson LK. Calcium requirements: new estimations for men and women by cross-sectional statistical analyses of calcium balance data from metabolic studies. Am J Clin Nutr. 2007;86:1054–63.
37. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SAA, Black HR, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354:669–83.
This article has been cited by other articles:
![]() |
I. Erdelyi, N. Levenkova, E. Y. Lin, J. T. Pinto, M. Lipkin, F. W. Quimby, and P. R. Holt Western-Style Diets Induce Oxidative Stress and Dysregulate Immune Responses in the Colon in a Mouse Model of Sporadic Colon Cancer J. Nutr., November 1, 2009; 139(11): 2072 - 2078. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||